NEW YORK (GenomeWeb) – The French National Authority for Health (HAS) earlier this week published a public health recommendation that advises to make circulating cell-free DNA testing for fetal trisomy 21 in maternal blood available to all pregnant women if their first trimester combined screen indicates an increased risk.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.